home / stock / dtc:cc / dtc:cc news

DTC:CC News and Press, Defence Therapeutics Inc. Class A From 04/24/23

Stock Information
Company Name: Defence Therapeutics Inc. Class A
Stock Symbol: DTC:CC
Market: CNQC
Website: defencetherapeutics.com
Menu
DTC:CC DTC:CC Quote DTC:CC Short DTC:CC News DTC:CC Articles DTC:CC Message Board
Get DTC:CC Alerts

News, Short Squeeze, Breakout and More Instantly...
DTC:CC - Defence Granted US Patent with Broad Coverage on Accum(TM)-based Vaccine Enhancer Platform Technology

Vancouver, British Columbia--(Newsfile Corp. - April 24, 2023) - Defence Therapeutics Inc. (CSE: DTC) (FSE: DTC) (OTC Pink: DTCFF) (" Defence " or the " Company "), a Canadian biopharmaceutical company developing novel immune-oncology vaccines and drug delivery technologies including Antibod...
DTC:CC - Defence's Novel Accum(TM)-mRNA Vaccine Now Administered for Testing on Cancer

Vancouver, British Columbia--(Newsfile Corp. - April 17, 2023) - Defence Therapeutics Inc. (CSE: DTC) (FSE: DTC) (OTC Pink: DTCFF) (" Defence " or the " Company "), a Canadian biopharmaceutical company specialized in the development of immune-oncology vaccines and drug delivery technologies, is p...

DTC:CC - RETRANSMISSION: Defence Breakthrough: Successfully Engineered Accum(TM)-mRNA Vaccine Creating a New Vaccine Platform. The in vivo Accum(TM)-mRNA Cancer Vaccine Program Begins

Vancouver, British Columbia--(Newsfile Corp. - April 11, 2023) - Defence Therapeutics Inc. (CSE: DTC) (FSE: DTC) (OTC Pink: DTCFF) (" Defence " or the " Company "), a Canadian biopharmaceutical company specialized in the development of immune-oncology vaccines and drug delivery technologies, is p...

DTC:CC - Defence Breakthrough: Successfully Engineered Accum(TM)-mRNA Vaccine Creating a New Vaccine Platform. The in vivo Accum(TM)-mRNA Cancer Vaccine Program Begins

Vancouver, British Columbia--(Newsfile Corp. - April 10, 2023) - Defence Therapeutics Inc. (CSE: DTC) (FSE: DTC) (OTC Pink: DTCFF) (" Defence " or the " Company "), a Canadian biopharmaceutical company specialized in the development of immune-oncology vaccines and drug delivery technologies, is p...
DTC:CC - Defence to Complete a Final Pre-Clinical Study Prior to IND Filings for the AccuTOX(TM) Phase I Cancer Trial at the City of Hope National Medical Center and Beckman Research Institute

Vancouver, British Columbia--(Newsfile Corp. - March 28, 2023) - Defence Therapeutics Inc. (CSE: DTC) (FSE: DTC) (OTC Pink: DTCFF) (" Defence " or the " Company "), a Canadian biopharmaceutical company specialized in the development of immune-oncology vaccines and drug delivery technologies is pl...

DTC:CC - Defence Therapeutics Announces Exercise of Warrants for Gross Proceeds of over $5 Million

Vancouver, British Columbia--(Newsfile Corp. - March 17, 2023) - Defence Therapeutics Inc. (CSE: DTC) (" Defence " or the " Company "), a Canadian biopharmaceutical company specialized in the development of immune-oncology vaccines and drug delivery technologies, is pleased to announce that over ...

DTC:CC - CSE Bulletin: INDEX - CSE 25 INDEX QUARTERLY REBALANCING

Toronto, Ontario--(Newsfile Corp. - Le 16 mars/March 2023) - The quarterly rebalancing of the CSE 25 Index will result in the following changes, effective after the close on Friday, March 17, 2023. Le rééquilibrage trimestriel de l’indice composé du CSE 25 entraînera...
DTC:CC - Defence Therapeutics Signs Collaboration Agreement with Orano to Develop the Next Generation of Targeted Radio-Immunotherapy for Cancer

Vancouver, British Columbia--(Newsfile Corp. - March 14, 2023) - Defence Therapeutics Inc. (CSE: DTC) (FSE: DTC) (OTC Pink: DTCFF) (" Defence " or the " Company "), is pleased to announce that it has signed a Collaboration Agreement with Orano Support SAS on behalf of Orano SA ("Orano"), a world-...

DTC:CC - Defence's Pipeline Advances to Multiple Phase I Clinical Trials

Vancouver, British Columbia--(Newsfile Corp. - February 27, 2023) - Defence Therapeutics Inc. (CSE: DTC) (FSE: DTC) (OTC Pink: DTCFF) (" Defence " or the " Company "), a Canadian biopharmaceutical company specialized in the development of immune-oncology vaccines and drug delivery technologi...

DTC:CC - Defence Delegates City of Hope to Initiate IND Filing for Its AccuTOX(TM) Cancer Program

Vancouver, British Columbia--(Newsfile Corp. - February 21, 2023) - Defence Therapeutics Inc. (CSE: DTC) (FSE: DTC) (OTC Pink: DTCFF) (" Defence " or the " Company "), a Canadian biopharmaceutical company specialized in the development of immune-oncology vaccines and drug delivery technologies is...
Previous 10 Next 10